Toggle navigation
Home
Search
Services
Blog
Contact
About
Cardiovascular Molecular Prognostic Kits
Bentley, Kevin L.
Genaissance Pharmaceuticals, Inc., New Haven, CT, United States
Search 4 grants from Kevin Bentley
Search grants from Genaissance Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study
Regulation of Islet Beta-Cell Function via Islet-Derived VGF Peptides
Optimizing Outcome After Pediatric Heart Transplantation
Mice with deficiences in the TNF/LT locus generated with
Information Interpretation in Patient Decision Support
Recently added grants:
The Role of Cardiolipin in the Tca Cycle: Implications for Barth Syndrome
A chromatin-based timer controlling T-cell development
Postpartum Weight Retention and Cardiometabolic Disparities: The Effects of Contexual, Psychosocial, and Behavioral Factors
Targeting Novel Pathways in JMML
The Role of PTPN11 in Myelofibrosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
9R44HL059114-02
Application #
2423742
Study Section
Special Emphasis Panel (ZRG2-SSS-Y (15))
Project Start
1997-08-29
Project End
1999-07-31
Budget Start
1997-08-29
Budget End
1998-07-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
Genaissance Pharmaceuticals, Inc.
Department
Type
DUNS #
City
New Haven
State
CT
Country
United States
Zip Code
06511
Related projects
NIH 1998
R44 HL
Cardiovascular Molecular Prognostic Kits
Bentley, Kevin L. / Genaissance Pharmaceuticals, Inc.
NIH 1997
R44 HL
Cardiovascular Molecular Prognostic Kits
Bentley, Kevin L. / Genaissance Pharmaceuticals, Inc.
Comments
Be the first to comment on Kevin Bentley's grant